Welcome to our dedicated page for SmartKem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SmartKem, Inc. filings document the public-company record for an organic semiconductor technology developer with common stock listed on Nasdaq under SMTK. The filings cover material-event reports, Securities Act registration statements, notices about annual-report timing, and disclosures tied to its advanced-materials and transistor-backplane business.
Recent regulatory documents address material definitive agreements, convertible notes, preferred stock financings, warrants, private placements, resale registration matters, Nasdaq listing-compliance disclosures, officer and subsidiary governance changes, shareholder voting matters, operating and financial results, and capital-structure updates involving common stock, preferred stock, and warrant securities.
SmartKem, Inc. is registering up to 160,260,999 shares of its Common Stock for resale by selling stockholders. The registered shares comprise 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares and 101,910,995 Additional RRA Shares. The Company will not receive proceeds from sales by the selling stockholders; the Company will receive proceeds only if Warrants are exercised for cash. The registration covers shares issuable upon conversion of Series A Preferred Stock and upon exercise of Warrants issued in private placements and an Additional Closing on June 22, 2026. The prospectus notes trading on Nasdaq under the symbol SMTK and discloses a last reported sale price of $0.2364 per share on July 1, 2026. The document also summarizes recent financings, including a senior secured notes financing of $3,750,000 (original principal) and an equity line commitment up to $500,000,000 or 19.99% of outstanding shares (Keystone).
SmartKem, Inc. filed an amendment to a Form S-3 to register 160,260,999 shares of Common Stock for resale by selling stockholders. The registered shares comprise 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares, and 101,910,995 Additional RRA Shares.
The prospectus states the company will not receive proceeds from resales by selling stockholders but will receive net proceeds from any Warrants exercised for cash. The filing also discloses recent financings and transactions, including an Equity Line providing up to $500,000,000 or 19.99% of shares, a $3,750,000 senior secured note issuance, and a $300,000 settlement payment tied to patent assignments. Shares trade on Nasdaq under the symbol SMTK, last reported at $0.2364 on July 1, 2026.
SmartKem, Inc. filed a shelf registration to permit resale of up to 160,260,999 shares of Common Stock by selling stockholders pursuant to private placements and related transactions, including 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares and 101,910,995 Additional RRA Shares. The company will not receive proceeds from these resales but will receive net proceeds if any warrants are exercised for cash.
The filing discloses recent financings and strategic transactions: an equity line of credit commitment up to $500,000,000 or 19.99% of outstanding shares, senior secured notes with an original principal of $3,750,000 (issued at a purchase price of $2,625,000), a $300,000 settlement payment and related patent assignment, and various private placements and conversions completed earlier in 2026.
SmartKem, Inc. entered into a new convertible bridge loan and completed an additional private financing. The company funded Ferrox Critical Minerals with a $2,500,000.00 Convertible Promissory Note bearing 5.0% annual interest and maturing on December 31, 2026, plus a $200,000.00 origination fee, tighter covenants, and broad rights of first refusal and exclusivity on major Ferrox transactions.
Separately, SmartKem closed an Additional Closing under its Series A Preferred Stock Securities Purchase Agreement, issuing 5,000 shares of Series A convertible preferred stock and 10,753,615 warrants for aggregate cash proceeds of approximately $4.0 million in a private placement relying on Regulation D and Section 4(a)(2) exemptions.
SmartKem, Inc. reported the results of its annual stockholder meeting, where all eleven proposals received the required approvals. Stockholders elected two Class II directors to terms through 2029 and gave advisory approval to the executive compensation program and annual say-on-pay frequency.
They ratified CBIZ CPAS P.C. as auditor for the year ending December 31, 2026. Stockholders also approved a major increase in authorized common shares from 300,000,000 to 5,000,000,000, an expansion of the 2021 Equity Incentive Plan share pool, and authority for the board to effect up to two reverse stock splits.
In addition, stockholders approved issuing common stock below the Nasdaq minimum price in excess of 19.99% of outstanding shares in connection with both the company’s Equity Line of Credit and its Series A convertible preferred stock and related warrants. They also adopted amendments allowing stockholder action by written consent and removing certain two-thirds supermajority voting requirements.
SmartKem, Inc. reported that the directors of its wholly owned UK subsidiary, SmartKem, Ltd., have instructed an administrator to begin placing that subsidiary into creditors voluntary liquidation. The company stated that this step will not impact its current operations and that it has not made any filing under any bankruptcy code or statutory reorganization scheme in either the United States or the United Kingdom. SmartKem, Inc. continues to operate its business.
SmartKem, Inc. reported a Q1 2026 net loss of $19.4 million, driven mainly by non-operating charges tied to an equity line of credit, derivative liabilities and debt settlement. Revenue was only $20 thousand, coming from sales of OTFT backplanes and TRUFLEX® materials.
Operating expenses fell to $2.6 million from $3.4 million a year earlier as research and development and general and administrative costs declined. After multiple equity and preferred stock financings, cash rose to $7.6 million, and stockholders’ equity turned positive at $5.4 million.
The company transferred its patent portfolio to a third party but retained process and formulation know‑how embodied in 40 trade secrets. Management states there is substantial doubt about SmartKem’s ability to continue as a going concern because current cash is not expected to fund the next 12 months, and a large equity line of credit and extensive warrants and preferred stock could significantly dilute existing shareholders.
SmartKem, Inc. is asking stockholders at its June 23, 2026 virtual annual meeting to elect two Class II directors and approve its executive pay program and say‑on‑pay frequency. Stockholders will also vote on ratifying CBIZ CPAS P.C. as auditor for the year ending December 31, 2026.
Major capital structure changes are proposed, including increasing authorized common stock from 300,000,000 to 5,000,000,000 shares, expanding the 2021 Equity Incentive Plan share pool from 1,643,692 to 2,144,622 shares, and granting the board discretion to implement up to two reverse stock splits. The company also seeks approval to issue common stock below the Nasdaq minimum price in excess of 19.99% of outstanding shares under an equity line of credit and upon conversion of Series A preferred stock and related warrants, and to amend its charter to allow stockholder action by written consent and to remove certain two‑thirds supermajority voting requirements.